Exploration of the Optimal Dosage of Cetirizine in the Treatment of Allergic Diseases in Chinese Children
Clinical trial NCT06288334 · UNKNOWN
Trial details
- NCT number
- NCT06288334
- Sponsor
- Peking University Third Hospital
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-06
- Primary completion
- 2024-03-31
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.